Screener
Medifast MED Net Income
Net Income at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Medifast in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The source filing: Medifast’s 10-Q, filed May 4, 2026.
- Filed
- May 4, 2026, 4:51 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-029898
| Line item | Three months ended March 31, 2026 | Three months ended March 31, 2025 |
|---|---|---|
| 1,354 | 1,788 | |
| Income (loss) before provision for income taxes | (1,941) | 526 |
| Provision for income taxes | 181 | 1,298 |
| Net loss | $(2,122) | $(772) |
| Loss per share - basic | $(0.19) | $(0.07) |
| Loss per share - diluted | $(0.19) | $(0.07) |
| Weighted average shares outstanding | ||
| Basic | 11,006 | 10,948 |
Item 1. – Financial Statements
FAQ
- What is Medifast's net income?
- Medifast (MED) reported net income of -$2.12M in Q1 2026.
- How has Medifast's net income changed year-over-year?
- Medifast's net income decreased by 174.9% year-over-year, from -$772K to -$2.12M.
- What is the long-term trend for Medifast's net income?
- Over 4 years (2021 to 2025), Medifast's net income has grown at a -41.9% compound annual growth rate (CAGR), from $164.03M to -$18.67M.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.
Ask your AI about Medifast's net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude